- Conditions
- Diabetes Mellitus, Hyperglycemia, Pancreas Ductal Adenocarcinoma
- Interventions
- Abdominal imaging, Enriching New-onset Diabetes for Pancreatic Cancer (ENDPAC) score
- Other
- Lead sponsor
- Pancreatic Cancer Action Network
- Other
- Eligibility
- 50 Years to 85 Years
- Enrollment
- 8,869 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2028
- U.S. locations
- 2
- States / cities
- Pasadena, California • Houston, Texas
Source: ClinicalTrials.gov public record
Updated Mar 11, 2026 · Synced May 6, 2026, 8:28 AM EDT